Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma and malignancy: an epidemiological study

A K Rosenthal1, J K McLaughlin, M S Linet

  • 1Department of Rheumatology, Medical College of Wisconsin.

Annals of the Rheumatic Diseases
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coprecipitation of Ce(III) oxide with UO<sub>2</sub>.

Journal of synchrotron radiation·2024
Same author

Ti <sub></sub>C <sub></sub> MXenes with fully saturated and thermally stable Cl terminations.

Nanoscale advances·2022
Same author

Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease.

Osteoarthritis and cartilage·2018
Same author

Quality Indicators of Nutritional Care Practice in Elderly Care.

The journal of nutrition, health & aging·2017
Same author

Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

Journal of internal medicine·2016
Same author

Response to letter from Lars Andersson.

Journal of internal medicine·2016
Same journal

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Annals of the rheumatic diseases·2026
Same journal

Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.

Annals of the rheumatic diseases·2026
Same journal

Response to Correspondence on 'Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial'.

Annals of the rheumatic diseases·2026
Same journal

Correspondence on 'Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial' by Hawkins et al.

Annals of the rheumatic diseases·2026
Same journal

Response to correspondence on 'Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis' by Kaundal et al.

Annals of the rheumatic diseases·2026
Same journal

Correspondence on 'Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis' by Kaundal et al.

Annals of the rheumatic diseases·2026
See all related articles

This study found a significantly increased risk of overall cancer, lung cancer, and non-Hodgkin's lymphoma in patients with scleroderma. Further research is needed to confirm these findings in larger populations.

Area of Science:

  • Rheumatology
  • Oncology
  • Epidemiology

Background:

  • Scleroderma is associated with potential increased cancer risk, but population-based evidence is limited.
  • Previous case reports suggest a link, necessitating robust epidemiological investigation.

Purpose of the Study:

  • To conduct a population-based follow-up study investigating cancer risk in patients diagnosed with scleroderma.
  • To determine if scleroderma patients have a higher incidence of specific cancers compared to the general population.

Main Methods:

  • Utilized the inpatient registry of the Uppsala health care region, Sweden (1955-1984) to identify 233 scleroderma patients.
  • Performed record linkage with the National Cancer Registry using unique patient identification codes.
  • Calculated standardized incidence ratios (SIRs) for all cancers and specific types, comparing observed to expected rates based on age and gender.

Related Experiment Videos

Main Results:

  • A significantly increased standardized incidence ratio (SIR) for all cancers (SIR = 2.4) was observed in scleroderma patients.
  • Significantly elevated SIRs were found for lung cancer (SIR = 7.8) and non-Hodgkin's lymphoma (SIR = 9.6).
  • Excluding cancers diagnosed within one year of scleroderma diagnosis yielded similar trends, though non-Hodgkin's lymphoma lost statistical significance.

Conclusions:

  • This study provides initial population-based evidence suggesting an increased cancer risk, including lung cancer and non-Hodgkin's lymphoma, in scleroderma patients.
  • Larger population-based studies are warranted to validate these findings and explore the detailed cancer risks associated with scleroderma.
  • Further investigation is crucial for a comprehensive understanding of the relationship between scleroderma and cancer incidence.